Rebooter
Nov 12, 12:29 AM
$NAUT $QSI Anodei is right, but it will be AI analysis of proteomic SEQUENCING data that makes the cure of proteins-based diseases like the ones he named (and others, like diabetes) possible, just as genomic sequencing led to numerous therapeutic breakthroughs.
Nautilus' Voyager platform is NOT a sequencing platform and will not produce unique data. It is an affinity-based assay platform. Think of it as a glorified catalog. Its purpose is to assist researchers in the identification of proteins, not in the sequencing and post-translational modification of proteins, which is where novel drug discovery and therapeutic breakthroughs will occur.
Suggesting Nautilus will be responsible for these breakthroughs is like saying a paper clip cured cancer since a paper clip was in the room when the breakthrough was made.
2 replies
